HUTCHMED (China) (HMDCF) Other Accumulated Expenses (2015 - 2025)
HUTCHMED (China) (HMDCF) reported Other Accumulated Expenses of $26.9 million for Q4 2025, down 18.48% year-over-year from $32.9 million in Q4 2024, and up 424.89% quarter-over-quarter from $5.1 million in Q2 2025.
HUTCHMED (China) (HMDCF) Other Accumulated Expenses (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HMDCF) has 11 years of Other Accumulated Expenses data on file, last reported at $26.9 million in Q4 2025.
- Other Accumulated Expenses for Q4 2025 came in at $26.9 million, down 18.48% year-over-year; the trailing twelve-month figure through Dec 2025 was $26.9 million (down 18.48% YoY), and the FY2025 annual result was $26.9 million, down 18.48% from the prior year.
- Other Accumulated Expenses rose to $26.9 million in Q4 2025 per HMDCF's latest filing, from $5.1 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $37.2 million in Q2 2022 and troughed at -$87000.0 in Q4 2021.
- A 5-year average of $12.7 million and a median of $6.8 million in 2023 frame the typical range for Other Accumulated Expenses.
- The sharpest annual moves came in 2021 and 2022: Other Accumulated Expenses slumped 101.99% in 2021, then surged 2514.94% in 2022.
- A 5-year view of Other Accumulated Expenses shows it stood at -$87000.0 in 2021, then surged by 2514.94% to $2.1 million in 2022, then jumped by 398.62% to $10.5 million in 2023, then jumped by 214.49% to $32.9 million in 2024, then retreated by 18.48% to $26.9 million in 2025.
- Business Quant data shows HMDCF's Other Accumulated Expenses at $26.9 million in Q4 2025, $5.1 million in Q2 2025, and $32.9 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | HUTCHMED (China) | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.86 Mn |
| Jun 30, 2025 | 5.12 Mn |
| Dec 31, 2024 | 32.95 Mn |
| Jun 30, 2024 | 6.05 Mn |
| Dec 31, 2023 | 10.48 Mn |
| Jun 30, 2023 | 6.81 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Jun 30, 2022 | 37.25 Mn |
| Dec 31, 2021 | -87,000.00 |
| Jun 30, 2021 | 6.86 Mn |
| Mar 31, 2021 | 5.58 Mn |
| Dec 31, 2020 | 4.38 Mn |
| Jun 30, 2020 | 3.93 Mn |
| Dec 31, 2019 | 5.86 Mn |
| Sep 30, 2019 | 4.07 Mn |
| Jun 30, 2019 | 5.36 Mn |
| Mar 31, 2019 | 3.21 Mn |
| Dec 31, 2018 | 3.54 Mn |
| Dec 31, 2017 | 3.57 Mn |
| Jun 30, 2017 | 1.52 Mn |